Sight Sciences Free Cash Flow Yield Over Time

SGHT Stock  USD 3.98  0.03  0.75%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sight Sciences Performance and Sight Sciences Correlation.
For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.
  
Free Cash Flow Yield is likely to gain to -0.18 in 2024.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sight Sciences. If investors know Sight will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sight Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.01)
Revenue Per Share
1.602
Quarterly Revenue Growth
0.007
Return On Assets
(0.19)
Return On Equity
(0.45)
The market value of Sight Sciences is measured differently than its book value, which is the value of Sight that is recorded on the company's balance sheet. Investors also form their own opinion of Sight Sciences' value that differs from its market value or its book value, called intrinsic value, which is Sight Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sight Sciences' market value can be influenced by many factors that don't directly affect Sight Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sight Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sight Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sight Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Free Cash Flow Yield Analysis

Compare Sight Sciences and related stocks such as Si Bone, Rapid Micro Biosystems, and Tactile Systems Tech Free Cash Flow Yield Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
SIBN(0.3897)(0.3897)(0.3897)(0.0283)(0.5454)(0.06)(0.0554)(0.0647)(0.0465)(0.0641)(0.0382)(0.0624)(0.11)(0.0329)(0.0345)
RPID(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0269)(0.0383)(0.1319)(1.3609)(1.4739)(1.4)
TCMD(0.0053)(0.0053)(0.0053)(0.0053)(0.0091)0.0050.04247.0E-4(6.0E-4)(0.0027)6.0E-47.0E-40.01430.10180.11
LUNG(0.023)(0.023)(0.023)(0.023)(0.023)(0.023)(0.023)(0.023)(0.023)(0.0154)(0.0128)(0.0389)(0.1484)(0.0793)(0.0833)
AORT(0.0829)0.10790.09480.04170.0090.02450.02020.0060.00410.00770.0056(0.0198)(0.0327)0.01560.0164
ANIK(0.1938)0.06850.06860.0460.06430.05240.01360.04050.06230.04670.01780.0063(0.0071)(0.0217)(0.0228)
OFIX0.02560.0608(0.0235)0.08720.05850.02080.04020.03670.03570.01320.069(0.0018)(0.0843)(0.2177)(0.21)
AVNS0.05240.05240.08480.09170.03280.01750.09270.047(0.0921)(0.078)(0.0104)0.03980.05640.0140.0133
FNA(0.004)(0.004)(0.004)(0.004)(0.004)(0.004)(0.004)(0.004)(0.004)(0.004)(0.0068)(0.0182)(0.0629)(0.0901)(0.0856)
VREX0.0690.0690.0690.0690.0690.0690.0690.0690.0690.0690.0690.04190.04190.0419(0.0052)
KIDS(0.0926)(0.0926)(0.0926)(0.0926)(0.0926)(0.0218)(0.0407)(0.1489)(0.048)(0.0434)(0.04)(0.0252)(0.0387)(0.0624)(0.0656)
NPCE(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0429)(0.0364)(0.1013)(1.0225)(0.0746)(0.0783)
CVRX(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0239)(0.0304)(0.1159)(0.1151)(0.0607)(0.0637)
CNMD0.23070.11210.09310.05310.04040.02710.01910.0370.03220.02370.01610.02340.00430.03170.0301

Sight Sciences and related stocks such as Si Bone, Rapid Micro Biosystems, and Tactile Systems Tech Free Cash Flow Yield description

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

My Equities

My Current Equities and Potential Positions

Sight Sciences
SGHT
Specialization
Health Care, Health Care Equipment & Services
LocationCalifornia; U.S.A
ExchangeNASDAQ Exchange
USD 3.98

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.